Skip to content

To Examine The Effect Of Shodhankesari Lepa And EUSOL Solution In People with Complaint Of Dushtra Vrana (Infected Wound)

COMPARATIVE CLINIC TRIAL TO EVALUATE THE SHODHAN EFFECT OF SHODHANKESARI LEPA AND EUSOL SOLUTION IN MANAGEMENT OF DUSHTA VRANA WITH SPECIAL REFERENCE TO INFECTED WOUND - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110323
Enrollment
60
Registered
2026-05-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

None listed

Sponsors

Dr . Shreyas Popat Shendkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient having age between 18 to 55 years. Patients irrespective of gender, economic class, caste, religion, Patient having sign and symptoms of Dushta Vrana having area less than length 10x 5 cm & max depth 0.5 cm will be randomly selected Patients having wound with the known case of Diabetes where diabetes in controlled.

Exclusion criteria

Exclusion criteria: Known cases of HIV, Hepatitis B, any systemic disease and uncontrolled diabetes. Patients suffering from wounds like. Tubercular Ulcers Venous Ulcers Leprotic Ulcers Malignant Ulcers Burns Wounds having excessive loss of Tissuesi.e. Wound include bone, and tendon injury, exposed bone.

Design outcomes

Primary

MeasureTime frame
To conduct comparative study between Shodhankesari Lepa And Eusol solution to compare which drug show the efficacy In Dushta Vran with special reference to infected woundTimepoint: 15 days

Secondary

MeasureTime frame
To study clinical textual review of Dustha vrana according to AyurvedaTimepoint: 15 days

Countries

India

Contacts

Public ContactDR. Shreyas popat shendkar

Late Kedari Redekar Ayurvedic Mahavidyalaya and PG Training and Research Center, Gadhinglaj

ranjitkadam96@gmail.com9595353549

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026